RISK OF MYELODYSPLASTIC SYNDROMES IN WELL-DIFFERENTIATED THYROID CANCERS TREATED WITH RADIOACTIVE IODINE

被引：0
|
作者：
Pleyer, C. [1 ]
Sidana, S. [1 ]
Erik, O. [2 ]
Radivoyevitch, T. [3 ]
Advani, A. S. [4 ]
Gerds, A. T. [4 ]
Carraway, H. [4 ]
Kalaycio, M. [4 ]
Maciejewski, J. P. [4 ]
Sekeres, M. A. [4 ]
Mukherjee, S. [4 ]
机构：
[1] Cleveland Clin, Dept Internal Med, Cleveland, OH 44106 USA
[2] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA
[3] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA
[4] Cleveland Clin, Leukemia Program, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA
来源：
LEUKEMIA RESEARCH | 2015年 / 39卷
关键词：
D O I：
10.1016/S0145-2126(15)30080-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
79
引用
收藏
页码：S38 / S39
页数：2
相关论文
共 50 条
  • [1] INCREASED RISK OF DEVELOPING MYELOID NEOPLASMS, INCLUDING MYELODYSPLASTIC SYNDROME, IN WELL-DIFFERENTIATED THYROID CANCERS TREATED WITH RADIOACTIVE IODINE
    Molenaar, R.
    Pleyer, C.
    Radivoyevitch, T.
    Carraway, H.
    Kalaycio, M.
    Maciejewski, J.
    Sekeres, M.
    Mukherjee, S.
    LEUKEMIA RESEARCH, 2017, 55 : S87 - S89
  • [2] Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine
    Molenaar, R. J.
    Pleyer, C.
    Radivoyevitch, T.
    Sidana, S.
    Godley, A.
    Advani, A. S.
    Gerds, A. T.
    Carraway, H. E.
    Kalaycio, M.
    Nazha, A.
    Adelstein, D. J.
    Nasr, C.
    Angelini, D.
    Maciejewski, J. P.
    Majhail, N.
    Sekeres, M. A.
    Mukherjee, S.
    LEUKEMIA, 2018, 32 (04) : 952 - 959
  • [3] Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine
    R J Molenaar
    C Pleyer
    T Radivoyevitch
    S Sidana
    A Godley
    A S Advani
    A T Gerds
    H E Carraway
    M Kalaycio
    A Nazha
    D J Adelstein
    C Nasr
    D Angelini
    J P Maciejewski
    N Majhail
    M A Sekeres
    S Mukherjee
    Leukemia, 2018, 32 : 952 - 959
  • [4] The role of radioactive iodine in the treatment of well-differentiated thyroid cancer
    Weigel, Ronald J.
    McDougall, I. Ross
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2006, 15 (03) : 625 - +
  • [5] Radioactive Iodine Treatment of Thyroid Cancer and Risk of Myelodysplastic Syndromes
    Pleyer, Christopher
    Sidana, Surbhi
    Radivoyevitch, Tomas
    Molenaar, Remco
    Godley, Andrew
    Offerman, Erik
    Advani, Anjali S.
    Gerds, Aaron T.
    Carraway, Hetty E.
    Kalaycio, Matt
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    Mukherjee, Sudipto
    BLOOD, 2015, 126 (23)
  • [6] Surgical approach and radioactive iodine therapy for small well-differentiated thyroid cancer
    Momesso, D. P.
    Vaisman, F.
    Caminha, L. S. C.
    Pessoa, C. H. C. N.
    Corbo, R.
    Vaisman, M.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2014, 37 (01) : 57 - 64
  • [7] The efficacy of radioactive iodine for the treatment of well-differentiated thyroid cancer with distant metastasis
    Lin, Jen-Der
    Kuo, Sheng-Fong
    Huang, Bie-Yui
    Lin, Shu-Fu
    Chen, Szu-Tah
    NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (12) : 1091 - 1096
  • [8] Surgical approach and radioactive iodine therapy for small well-differentiated thyroid cancer
    D. P. Momesso
    F. Vaisman
    L. S. C. Caminha
    C. H. C. N. Pessoa
    R. Corbo
    M. Vaisman
    Journal of Endocrinological Investigation, 2014, 37 : 57 - 64
  • [9] Sorafenib in radioactive iodine-refractory well-differentiated metastatic thyroid cancer
    McFarland, Daniel C.
    Misiukiewicz, Krzysztof J.
    ONCOTARGETS AND THERAPY, 2014, 7 : 1291 - 1299
  • [10] Use of radioactive iodine for thyroid remnant ablation in well-differentiated thyroid carcinoma to replace thyroid reoperation
    Lin, JD
    Chao, TC
    Huang, MJ
    Weng, HF
    Tzen, KY
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (01): : 77 - 81
12345